The role of stem cells in the treatment of diabetic foot ulcers

Diabetes Research and Clinical Practice

Volumn 96, Issue 1, 2012, Pages 1-9

  Blumberg, Sheila N ^a   Berger, Alexandra ^a   Hwang, Lisa ^a   Pastar, Irena ^a   Warren, Stephen M ^a   Chen, Weiliam ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic wounds; DFU; Diabetic foot ulcers; Stem cells; Wound healing

Indexed keywords

FIBRIN GLUE;

ADIPOSE TISSUE CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL SUBPOPULATION; CHRONIC WOUND; CLINICAL EFFECTIVENESS; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETIC FOOT; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HUMAN; LIMB ISCHEMIA; LIMB SALVAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PLACENTA VILLUS; REVIEW; STEM CELL TRANSPLANTATION; STROMA CELL; THERAPY EFFECT; TREATMENT PLANNING; WOUND HEALING;

DIABETIC FOOT; HUMANS; STEM CELLS; WOUND HEALING;

EID: 84858750133     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.032     Document Type: Review

References (111)

1. Singer A.J., Clark R.A. Cutaneous wound healing. N Engl J Med 1999, 341(10):738-746.
2. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997, 276(5309):75-81.
3. Delavary B.M., van der Veer W.M., van Egmond M., Niessen F.B., Beelen R.H. Macrophages in skin injury and repair. Immunobiology 2011.
4. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83(3):835-870.
5. Werner S., Krieg T., Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007, 127(5):998-1008.
6. Fu X., Li X., Cheng B., Chen W., Sheng Z. Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. Wound Repair Regen 2005, 13(2):122-130.
7. Brem H., Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007, 117(5):1219-1222.
8. Pilcher B.K., Wang M., Qin X.J., Parks W.C., Senior R.M., Welgus H.G. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann NY Acad Sci 1999, 878:12-24.
9. Nagaoka T., Kaburagi Y., Hamaguchi Y., Hasegawa M., Takehara K., Steeber D.A., et al. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 2000, 157(1):237-247.
10. Madlener M., Parks W.C., Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998, 242(1):201-210.
11. Parks W.C. Matrix metalloproteinases in repair. Wound Repair Regen 1999, 7(6):423-432.
12. Mast B.A., Schultz G.S. Interactions of cytokines: growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996, 4(4):411-420.
13. Marhoffer W., Stein M., Maeser E., Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992, 15(2):256-260.
14. Geerlings S.E., Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999, 26(3-4):259-265.
15. Stojadinovic O., Brem H., Vouthounis C., Lee B., Fallon J., Stallcup M., et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005, 167(1):59-69.
16. Brem H., Stojadinovic O., Diegelmann R.F., Entero H., Lee B., Pastar I., et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 2007, 13(1-2):30-39.
17. Siqueira M.F., Li J., Chehab L., Desta T., Chino T., Krothpali N., et al. Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia 2010, 53(2):378-388.
18. Loots M.A., Lamme E.N., Mekkes J.R., Bos J.D., Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999, 291(2-3):93-99.
19. Brem H., Golinko M.S., Stojadinovic O., Kodra A., Diegelmann R.F., Vukelic S., et al. Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. J Transl Med 2008, 6:75.
20. Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C., et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32(2):287-294.
21. Consensus development conference on diabetic foot wound care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 1999, 22(8):1354-1360.
22. Miyajima S., Shirai A., Yamamoto S., Okada N., Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2006, 71(3):272-279.
23. Izumi Y., Satterfield K., Lee S., Harkless L.B. Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care 2006, 29(3):566-570.
24. Faglia E., Clerici G., Clerissi J., Gabrielli L., Losa S., Mantero M., et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg 2006, 32(5):484-490.
25. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31(3):596-615.
26. Wu Y., Wang J., Scott P.G., Tredget E.E. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen 2007, 15(Suppl. 1):S18-S26.
27. Kataoka K., Medina R.J., Kageyama T., Miyazaki M., Yoshino T., Makino T., et al. Participation of adult mouse bone marrow cells in reconstitution of skin. Am J Pathol 2003, 163(4):1227-1231.
28. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25(10):2648-2659.
29. Li H., Fu X., Ouyang Y., Cai C., Wang J., Sun T. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 2006, 326(3):725-736.
30. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22(5):649-658.
31. Miao Z., Jin J., Chen L., Zhu J., Huang W., Zhao J., et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 2006, 30(9):681-687.
32. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103(5):1669-1675.
33. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003, 21(1):105-110.
34. Gang E.J., Jeong J.A., Hong S.H., Hwang S.H., Kim S.W., Yang I.H., et al. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 2004, 22(4):617-624.
35. Mareschi K., Biasin E., Piacibello W., Aglietta M., Madon E., Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 2001, 86(10):1099-1100.
36. Klein J.D., Fauza D.O. Amniotic and placental mesenchymal stem cell isolation and culture. Methods Mol Biol 2011, 698:75-88.
37. Tran T.C., Kimura K., Nagano M., Yamashita T., Ohneda K., Sugimori H., et al. Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization. J Cell Physiol 2011, 226(1):224-235.
38. Prather W.R., Toren A., Meiron M., Ofir R., Tschope C., Horwitz E.M. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 2009, 11(4):427-434.
39. Prather W. Pluristem Therapeutics, Inc. Regen Med 2008, 3(1):117-122.
40. Can A., Balci D. Isolation, culture, and characterization of human umbilical cord stroma-derived mesenchymal stem cells. Methods Mol Biol 2011, 698:51-62.
41. Luo G., Cheng W., He W., Wang X., Tan J., Fitzgerald M., et al. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood. Wound Repair Regen 2010, 18(5):506-513.
42. db mice. Ann Plast Surg 2010, 65(6):565-572.
43. Chang Y.J., Shih D.T., Tseng C.P., Hsieh T.B., Lee D.C., Hwang S.M. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006, 24(3):679-685.
44. Jager M., Wild A., Lensing-Hohn S., Krauspe R. Influence of different culture solutions on osteoblastic differentiation in cord blood and bone marrow derived progenitor cells. Biomed Tech (Berl) 2003, 48(9):241-244.
45. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
46. Lerou P. Embryonic stem cell derivation from human embryos. Methods Mol Biol 2011, 767:31-35.
47. Chiao E., Kmet M., Behr B., Baker J. Derivation of human embryonic stem cells in standard and chemically defined conditions. Methods Cell Biol 2008, 86:1-14.
48. Klimanskaya I., Chung Y., Becker S., Lu S.J., Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature 2006, 444(7118):481-485.
49. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116(21):2409-2419.
50. Ferreira L.S., Gerecht S., Shieh H.F., Watson N., Rupnick M.A., Dallabrida S.M., et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res 2007, 101(3):286-294.
51. Lee K.B., Choi J., Cho S.B., Chung J.Y., Moon E.S., Kim N.S., et al. Topical embryonic stem cells enhance wound healing in diabetic rats. J Orthop Res 2011, 29(10):1554-1562.
52. Lee M.J., Kim J., Lee K.I., Shin J.M., Chae J.I., Chung H.M. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy 2011, 13(2):165-178.
53. Jin P., Zhang X., Wu Y., Li L., Yin Q., Zheng L., et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010, 42(7):2745-2752.
54. Falanga V., Iwamoto S., Chartier M., Yufit T., Butmarc J., Kouttab N., et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007, 13(6):1299-1312.
55. Prochazka V., Gumulec J., Chmelova J., Klement P., Klement G.L., Jonszta T., et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr Lek 2009, 55(3):173-178.
56. Hermann P.C., Huber S.L., Herrler T., von Hesler C., Andrassy J., Kevy S.V., et al. Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant 2008, 16(10):1059-1069.
57. Matoba S., Tatsumi T., Murohara T., Imaizumi T., Katsuda Y., Ito M., et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008, 156(5):1010-1018.
58. Amann B., Luedemann C., Ratei R., Schmidt-Lucke J.A. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009, 18(3):371-380.
59. Badiavas E.V., Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003, 139(4):510-516.
60. Lu D., Chen B., Liang Z., Deng W., Jiang Y., Li S., et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011.
61. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967.
62. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5(4):434-438.
63. Tepper O.M., Carr J., Allen R.J., Chang C.C., Lin C.D., Tanaka R., et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010, 59(8):1974-1983.
64. Albiero M., Menegazzo L., Boscaro E., Agostini C., Avogaro A., Fadini G.P. Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia 2010.
65. Zheng H., Fu G., Dai T., Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007, 50(3):274-280.
66. Yu J.X., Huang X.F., Lv W.M., Ye C.S., Peng X.Z., Zhang H., et al. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. J Vasc Surg 2009, 50(3):608-616.
67. Bermudez D.M., Xu J., Herdrich B.J., Radu A., Mitchell M.E., Liechty K.W. Inhibition of stromal cell-derived factor-1alpha further impairs diabetic wound healing. J Vasc Surg 2011.
68. Awad O., Dedkov E.I., Jiao C., Bloomer S., Tomanek R.J., Schatteman G.C. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler Thromb Vasc Biol 2006, 26(4):758-764.
69. Capla J.M., Grogan R.H., Callaghan M.J., Galiano R.D., Tepper O.M., Ceradini D.J., et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 2007, 119(1):59-70.
70. db diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing. Circ Res 2003, 92(11):1247-1253.
71. Fiorina P., Pietramaggiori G., Scherer S.S., Jurewicz M., Mathews J.C., Vergani A., et al. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 2010, 19(11):1369-1381.
72. Valbonesi M., Giannini G., Migliori F., Dalla Costa R., Dejana A.M. Cord blood (CB) stem cells for wound repair. Preliminary report of 2 cases. Transfus Apher Sci 2004, 30(2):153-156.
73. Pedroso D.C., Tellechea A., Moura L., Fidalgo-Carvalho I., Duarte J., Carvalho E., et al. Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells. PloS one 2011, 6(1):e16114.
74. Ravari H., Hamidi-Almadari D., Salimifar M., Bonakdaran S., Parizadeh M.R., Koliakos G. Treatment of non-healing wounds with autologous bone marrow cells: platelets, fibrin glue and collagen matrix. Cytotherapy 2011, 13(6):705-711.
75. Ramsamudara K. A clinical trial on diabetic foot using peripheral blood derived stem cells for treating critical limb ischemia 2011, [cited 2011 August 31st]; Clinical trials.gov identifier: NCT00922389]. Available from http://clinicaltrials.gov/ct2/results?term=hematopoietic+stem+cell+and+diabetic+foot+ulcer.
76. Tschoepe D. Induced wound healing by application of expanded bone marrow stem cells in diabetic patients with critical limb ischemia 2011, [cited 2011 August 31st]; Clinicaltrials.gov identifier: NCT01065337]. Available from http://clinicaltrials.gov/ct2/show/NCT01065337?term=hematopoietic+stem+cell+and+diabetic+foot+ulcer&rank=3.
77. Strem B.M., Hedrick M.H. The growing importance of fat in regenerative medicine. Trends Biotechnol 2005, 23(2):64-66.
78. Fraser J.K., Wulur I., Alfonso Z., Hedrick M.H. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006, 24(4):150-154.
79. Di Rocco G., Gentile A., Antonini A., Ceradini F., Wu J.C., Capogrossi M.C., et al. Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int 2010, 2011:304-562.
80. Lin C.D., Allori A.C., Macklin J.E., Sailon A.M., Tanaka R., Levine J.P., et al. Topical lineage-negative progenitor-cell therapy for diabetic wounds. Plast Reconstr Surg 2008, 122(5):1341-1351.
81. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7(2):211-228.
82. Winter A., Breit S., Parsch D., Benz K., Steck E., Hauner H., et al. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 2003, 48(2):418-429.
83. Maharlooei M.K., Bagheri M., Solhjou Z., Jahromi B.M., Akrami M., Rohani L., et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res Clin Pract 2011.
84. Nie C., Yang D., Morris S.F. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. Med Hypotheses 2009, 72(6):679-682.
85. Lobmann R., Schultz G., Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005, 28(2):461-471.
86. Yager D.R., Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair Regen 1999, 7(6):433-441.
87. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors: matrices, and forces combine and control stem cells. Science 2009, 324(5935):1673-1677.
88. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103(11):1204-1219.
89. Ho W., Tawil B., Dunn J.C., Wu B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 2006, 12(6):1587-1595.
90. Gorodetsky R., Clark R.A., An J., Gailit J., Levdansky L., Vexler A., et al. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. J Invest Dermatol 1999, 112(6):866-872.
91. Horch R.E., Bannasch H., Kopp J., Andree C., Stark G.B. Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant 1998, 7(3):309-317.
92. Bensaid W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003, 24(14):2497-2502.
93. Park H., Karajanagi S., Wolak K., Aanestad J., Daheron L., Kobler J.B., et al. Three-dimensional hydrogel model using adipose-derived stem cells for vocal fold augmentation. Tissue Eng Part A 2010, 16(2):535-543.
94. Weiss E., Yamaguchi Y., Falabella A., Crane S., Tokuda Y., Falanga V. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking. J Cell Physiol 1998, 174(1):58-65.
95. Corbett S.A., Schwarzbauer J.E. Fibronectin-fibrin cross-linking: a regulator of cell behavior. Trends Cardiovasc Med 1998, 8(8):357-362.
96. Catelas I., Sese N., Wu B.M., Dunn J.C., Helgerson S., Tawil B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 2006, 12(8):2385-2396.
97. Fisher O.Z., Khademhosseini A., Langer R., Peppas N.A. Bioinspired materials for controlling stem cell fate. Acc Chem Res 2010, 43(3):419-428.
98. Liu S., Tay R., Khan M., Ee P., Hedrick J., Yang Y. Synthetic Hydrogels for controlled stem cell differentiation. Soft Matter 2010, 6:67-81.
99. Nuttelman C.R., Tripodi M.C., Anseth K.S. In vitro osteogenic differentiation of human mesenchymal stem cells photoencapsulated in PEG hydrogels. J Biomed Mater Res A 2004, 68(4):773-782.
100. Nuttelman C.R., Tripodi M.C., Anseth K.S. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 2005, 24(3):208-218.
101. Karoubi G., Ormiston M.L., Stewart D.J., Courtman D.W. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials 2009, 30(29):5445-5455.
102. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002, 23(22):4315-4323.
103. Pankov R., Yamada K.M. Fibronectin at a glance. J Cell Sci 2002, 115(Pt 20):3861-3863.
104. Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., Cheresh D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001, 155(3):459-470.
105. Chen L., Tredget E.E., Liu C., Wu Y. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One 2009, 4(9):e7119.
106. Blume P., Driver V.R., Tallis A.J., Kirsner R.S., Kroeker R., Payne W.G., et al. Formulated collagen gel accelerates healing rate immediately after application in patients with diabetic neuropathic foot ulcers. Wound Repair Regen 2011, 19(3):302-308.
107. Robbins S.L., Kumar V., Cotran R.S. Robbins and Cotran pathologic basis of disease 2010, Saunders/Elsevier, Philadelphia, PA, xiv, 1450 pp. 8th ed.
108. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97(11):1093-1107.
109. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13(12):4279-4295.
110. Kim W.S., Park B.S., Sung J.H., Yang J.M., Park S.B., Kwak S.J., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007, 48(1):15-24.
111. Wang F., Li Z., Khan M., Tamama K., Kuppusamy P., Wagner W.R., et al. Injectable: rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater 2010, 6(6):1978-1991.